BChE-IN-44

CAT: 0804-HY-178356Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-178356Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BChE-IN-44 is a potent, brain-penetrant, highly selective BChE inhibitor [equine BChE IC50 = 18.00 pM, human BChE IC50 = 1.50 nM]. BChE-IN-44 shows neuroprotective effects against the Aβ1-42-induced injury model and inhibitory effects on Aβ1-42 self-aggregation. BChE-IN-44 reduces the levels of inflammatory factors (NO, IL-6, and TNF-α) in Lipopolysaccharides (HY-D1056) -induced BV2 cells. BChE-IN-44 can significantly ameliorate Scopolamine (HY-N0296) -induced cognition impairment. BChE-IN-44 exhibits capacity in the regulation of BChE and acetylcholine levels in the mouse hippocampus. BChE-IN-44 can be used for the study of Alzheimer’s disease (AD) [1].
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Interleukin Related; nAChR; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
CC1=CC(O)=C(C=C1)C(NCCC2=CNC3=CC=C(C=C23)OC(N4CCC4)=O)=O
Molecular Formula
C22H23N3O4
Molecular Weight
393.44
References & Citations
[1]Zhao Y, et al. Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating Alzheimer's disease. Eur J Med Chem. 2025 Dec 5;299:118071.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE; IL-6

Popular Products